NeueHealth Debt to Equity Ratio 2019-2025 | NEUE
Current and historical debt to equity ratio values for NeueHealth (NEUE) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. NeueHealth debt/equity for the three months ending March 31, 2025 was 0.00.
| NeueHealth Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $2.26B | $-1.36B | -1.66 |
| 2024-12-31 | $1.90B | $-1.36B | -1.40 |
| 2024-09-30 | $2.05B | $-1.35B | -1.52 |
| 2024-06-30 | $2.20B | $-1.31B | -1.69 |
| 2024-03-31 | $2.37B | $-1.26B | -1.88 |
| 2023-12-31 | $2.49B | $-1.26B | -1.97 |
| 2023-09-30 | $3.11B | $-1.05B | -2.95 |
| 2023-06-30 | $4.83B | $-0.44B | -11.08 |
| 2023-03-31 | $5.19B | $-0.34B | -15.26 |
| 2022-12-31 | $4.87B | $-0.20B | -24.27 |
| 2022-09-30 | $4.24B | $0.37B | 11.49 |
| 2022-06-30 | $4.58B | $0.68B | 6.71 |
| 2022-03-31 | $4.32B | $0.96B | 4.51 |
| 2021-12-31 | $2.45B | $1.15B | 2.14 |
| 2021-09-30 | $1.64B | $1.94B | 0.85 |
| 2021-06-30 | $1.45B | $2.15B | 0.67 |
| 2021-03-31 | $0.00B | $0.00B | 0.00 |
| 2020-12-31 | $0.00B | 0.00 | |
| 2020-09-30 | $0.00B | $0.00B | 0.00 |
| 2020-06-30 | $0.00B | $0.00B | 0.00 |
| 2019-12-31 | $1.08B | $-0.26B | -4.12 |
| 2018-12-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.061B | $0.937B |
| NeueHealth is a healthcare company which provides health insurance policies principally in the United States. Its operating segments include Bright HealthCare and Consumer Care. NeueHealth, formerly known as Bright Health Group Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.565B | 26.36 |
| Elevance Health (ELV) | United States | $91.235B | 11.77 |
| CVS Health (CVS) | United States | $79.418B | 9.87 |
| Cencora (COR) | United States | $56.719B | 19.73 |
| DiDi Global (DIDIY) | China | $21.932B | 33.29 |
| Natera (NTRA) | United States | $20.928B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $13.109B | 13.88 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.943B | 0.00 |
| CochLear (CHEOY) | Australia | $11.734B | 0.00 |
| Revvity (RVTY) | United States | $11.115B | 19.13 |
| ICON (ICLR) | Ireland | $10.559B | 9.82 |
| Viatris (VTRS) | United States | $10.281B | 3.53 |
| Doximity (DOCS) | United States | $10.038B | 46.76 |
| Avantor (AVTR) | United States | $9.104B | 13.23 |
| Medpace Holdings (MEDP) | United States | $8.794B | 23.36 |
| HealthEquity (HQY) | United States | $8.442B | 41.53 |
| Sonic Healthcare (SKHHY) | Australia | $8.311B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.944B | 13.61 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.201B | 38.89 |
| Bausch + Lomb (BLCO) | Canada | $4.160B | 24.52 |
| Sotera Health (SHC) | United States | $3.616B | 20.55 |
| Alignment Healthcare (ALHC) | United States | $3.213B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.025B | 39.33 |
| Concentras Parent (CON) | United States | $2.892B | 16.71 |
| Organon (OGN) | United States | $2.340B | 2.49 |
| Ardent Health Partners (ARDT) | United States | $2.167B | 9.24 |
| GeneDx Holdings (WGS) | United States | $2.026B | 78.04 |
| Premier (PINC) | United States | $1.903B | 14.44 |
| Progyny (PGNY) | United States | $1.843B | 40.57 |
| PACS (PACS) | United States | $1.623B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.411B | 28.21 |
| Teladoc Health (TDOC) | United States | $1.282B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.277B | 9.72 |
| Establishment Labs Holdings (ESTA) | $1.065B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.986B | 15.39 |
| Nutex Health (NUTX) | United States | $0.981B | 14.82 |
| Agilon Health (AGL) | United States | $0.969B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.858B | 8.04 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.679B | 4.57 |
| InnovAge Holding (INNV) | United States | $0.566B | 0.00 |
| Enhabit (EHAB) | United States | $0.539B | 44.38 |
| Auna S.A (AUNA) | Luxembourg | $0.524B | 13.88 |
| Sonida Senior Living (SNDA) | United States | $0.494B | 0.00 |
| LifeMD (LFMD) | United States | $0.481B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.404B | 0.00 |
| SBC Medicals (SBC) | United States | $0.353B | 0.00 |
| Oncology Institute (TOI) | United States | $0.231B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.211B | 0.00 |
| Beauty Health (SKIN) | United States | $0.205B | 0.00 |
| DocGo (DCGO) | United States | $0.148B | 24.17 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.087B | 0.00 |
| KindlyMD (KDLY) | United States | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.039B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.032B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |